Condensed Consolidated Statements of Stockholders' Equity (Deficit) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Balance at Dec. 31, 2013	$ (11,463,965)	$ 1,000	$ 1,000	$ (11,465,965)
Balance (in shares) at Dec. 31, 2013	999,999	999,999
Increase (Decrease) in Stockholders' Equity
Sale of common stock in our initial public offering	17,728,815	3,105	17,725,710
Sale of common stock in our initial public offering (in shares)		3,105,000
Offering costs of our initial public offering	(2,388,027)		(2,388,027)
Reclassification of warrant liabilities	3,658,411		3,658,411
Conversion of convertible notes	9,400,000	2,787	9,397,213
Conversion of convertible notes (in shares)		2,787,667
Write -off of derivative liability upon conversion of notes payable	5,526,003		5,526,003
Issuance of common stock from vesting of restricted stock units, net of shares used to pay taxes	76,322	10	76,322
Issuance of common stock from vesting of restricted stock units, net of shares used to pay taxes (in shares)		10,174
Fair value of stock options issued to advisors and consultants	226,485		226,485
Sale of warrants	1,000		1,000
Issuance of warrants to consultants	19,873		19,873
Stock-based compensation	333,199		333,199
Net loss	(7,559,337)			(7,559,337)
Balance at Sep. 30, 2014	$ 16,459,974	$ 6,902	$ 35,478,374	$ (19,025,302)
Balance (in shares) at Sep. 30, 2014	6,902,840	6,902,840